title: Immunodynamics of basiliximab in liver allograft recipient under continuous hemodiafiltration.
authors.forename: Susumu
authors.initials: S
authors.lastname: Eguchi
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Yanaga
authors.forename: Sadayuki
authors.initials: S
authors.lastname: Okudaira
authors.forename: Shungo
authors.initials: S
authors.lastname: Miyamoto
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Itoh
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Inuo
authors.forename: Kohsho
authors.initials: K
authors.lastname: Yamanouchi
authors.forename: Takayuki
authors.initials: T
authors.lastname: Hamada
authors.forename: Junichiro
authors.initials: J
authors.lastname: Furui
authors.forename: Takashi
authors.initials: T
authors.lastname: Kanematsu
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000097:blood; D000077552:Basiliximab; D017583:Hemodiafiltration; D019698:Hepatitis C, Chronic / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011993:Recombinant Fusion Proteins; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab